The test was not expected to detect IgM antibodies resulting from a response to vaccination with a SARS-CoV-2 spike sequence, but rather to serve as a measure of an immune response to potential infection with SARS-CoV-2 during the first weeks after vaccination. The gene discussed is CD40LG; the disease is infection.